Compile Data Set for Download or QSAR
Report error Found 90 Enz. Inhib. hit(s) with all data for entry = 7175
TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179558BDBM179558(US9126980, 3)
Affinity DataIC50: 90.4nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179558BDBM179558(US9126980, 3)
Affinity DataIC50: 127nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179566BDBM179566(US9126980, 11)
Affinity DataIC50: 253nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179580BDBM179580(US9126980, 25)
Affinity DataIC50: 255nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179597BDBM179597(US9126980, 42)
Affinity DataIC50: 255nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179590BDBM179590(US9126980, 35)
Affinity DataIC50: 257nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179593BDBM179593(US9126980, 38)
Affinity DataIC50: 269nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179597BDBM179597(US9126980, 42)
Affinity DataIC50: 270nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179590BDBM179590(US9126980, 35)
Affinity DataIC50: 272nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179600BDBM179600(US9126980, 45)
Affinity DataIC50: 293nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179557BDBM179557(US9126980, 2)
Affinity DataIC50: 295nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179566BDBM179566(US9126980, 11)
Affinity DataIC50: 296nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179583BDBM179583(US9126980, 28)
Affinity DataIC50: 311nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179582BDBM179582(US9126980, 27)
Affinity DataIC50: 315nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179593BDBM179593(US9126980, 38)
Affinity DataIC50: 328nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179581BDBM179581(US9126980, 26)
Affinity DataIC50: 370nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179557BDBM179557(US9126980, 2)
Affinity DataIC50: 377nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179560BDBM179560(US9126980, 5)
Affinity DataIC50: 412nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179580BDBM179580(US9126980, 25)
Affinity DataIC50: 427nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179583BDBM179583(US9126980, 28)
Affinity DataIC50: 448nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179582BDBM179582(US9126980, 27)
Affinity DataIC50: 454nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179573BDBM179573(US9126980, 18)
Affinity DataIC50: 457nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179561BDBM179561(US9126980, 6)
Affinity DataIC50: 465nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179579BDBM179579(US9126980, 24)
Affinity DataIC50: 466nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179562BDBM179562(US9126980, 7)
Affinity DataIC50: 474nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179601BDBM179601(US9126980, 46)
Affinity DataIC50: 475nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179571BDBM179571(US9126980, 16)
Affinity DataIC50: 475nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179600BDBM179600(US9126980, 45)
Affinity DataIC50: 480nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179581BDBM179581(US9126980, 26)
Affinity DataIC50: 494nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179587BDBM179587(US9126980, 32)
Affinity DataIC50: 512nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179556BDBM179556(US9126980, 1)
Affinity DataIC50: 519nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179599BDBM179599(US9126980, 44)
Affinity DataIC50: 522nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179584BDBM179584(US9126980, 29)
Affinity DataIC50: 529nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179596BDBM179596(US9126980, 41)
Affinity DataIC50: 531nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179569BDBM179569(US9126980, 14)
Affinity DataIC50: 559nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179595BDBM179595(US9126980, 40)
Affinity DataIC50: 562nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179561BDBM179561(US9126980, 6)
Affinity DataIC50: 563nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179594BDBM179594(US9126980, 39)
Affinity DataIC50: 566nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179573BDBM179573(US9126980, 18)
Affinity DataIC50: 585nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179560BDBM179560(US9126980, 5)
Affinity DataIC50: 609nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179587BDBM179587(US9126980, 32)
Affinity DataIC50: 631nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179594BDBM179594(US9126980, 39)
Affinity DataIC50: 632nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179562BDBM179562(US9126980, 7)
Affinity DataIC50: 638nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179571BDBM179571(US9126980, 16)
Affinity DataIC50: 640nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179589BDBM179589(US9126980, 34)
Affinity DataIC50: 641nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179579BDBM179579(US9126980, 24)
Affinity DataIC50: 652nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179596BDBM179596(US9126980, 41)
Affinity DataIC50: 660nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179563BDBM179563(US9126980, 8)
Affinity DataIC50: 664nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179601BDBM179601(US9126980, 46)
Affinity DataIC50: 666nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Novartis

US Patent
LigandChemical structure of BindingDB Monomer ID 179595BDBM179595(US9126980, 40)
Affinity DataIC50: 673nMAssay Description:Methods for Determining IC50s.The present method includes utility of a Surface plasmon resonance (SPR)- based biosensor (Biacore GE Healthcare, Uppsa...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
US Patent

Displayed 1 to 50 (of 90 total ) | Next | Last >>
Jump to: